Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their manufacturing operations to China based CMOs. Further, in order to meet the growing demand for their services, Chinese CMOs are actively consolidating / expanding their capabilities through partnerships and / or dedicated expansion initiatives.  


To order this 250+ page report, which features 100+ figures and 120+ tables, please visit this link


The USD 2.6 billion (by 2030) financial opportunity within the China biopharmaceutical contract manufacturing market has been analyzed across the following segments:

Type of Product

  • API
  • FDF

Type of Expression System Used

  • Mammalian
  • Microbial
  • Others

Scale of Operation

  • Preclinical / Clinical
  • Commercial

Size of Manufacturer

  • Small
  • Mid-sized
  • Large / Very Large

Type of Biologic

  • Antibody
  • Vaccine
  • Others


The China Biopharmaceutical Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

ChemPartner Biologics

JHL Biotech

JOINN Biologics


Mycenax Biotech

WuXi AppTec


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Case Study: Comparison of Small Molecules and Large Molecules

5. Competitive Landscape

6. Company Profiles

7. Partnerships

8. Recent Expansions

9. Clinical Trial Analysis

10. Regional Capability Analysis

11. Capacity Analysis

12. Big Pharma Biopharmaceutical Manufacturing Initiatives in China

13. Make Versus Buy Decision Making Framework 

14. Market Sizing and Opportunity Analysis


15. COVID-19 Impact on China Biopharmaceutical CMO Market 

16. SWOT Analysis

17. Future of the China Biopharmaceutical CMO Market

18. Interview Transcripts






To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415



Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe